Does Acute THC Reduce Effort for Rewards? Why That Is Not a Diagnosis of Chronic Apathy

Oral THC reduced willingness to choose a demanding reward task in a controlled study of women. The result concerns an acute decision under experimental conditions, not proof of a permanent “amotivational syndrome.”

The choice being tested

Wardle and colleagues analyzed a double-blind, counterbalanced comparison of oral THC and placebo in young women with prior cannabis experience who were not regular users. Participants repeatedly chose between easier and harder tasks with different reward amounts and probabilities.

This was a secondary analysis within a larger study. The pandemic abbreviated the dosing schedule for some participants, so not everyone completed all dose conditions.

Choice and movement speed were separated

THC reduced hard-task choices, particularly at moderate to high expected reward values. The higher dose differed significantly from placebo; the lower dose did not clearly differ from either comparison condition.

THC also slowed performance, but the choice effect remained after statistical adjustment for psychomotor slowing. The analysis therefore did not simply equate slower button pressing with lower motivation.

What the experiment cannot establish

The task does not reproduce every reason someone works, studies, cares for family, or pursues a goal. Results from a selected group of young women do not automatically generalize to men, older adults, or highly tolerant users.

The study did not establish long-term changes after cannabis cessation, a diagnosis of apathy, or an individual’s intent in a real event. A careful opinion distinguishes acute effort-based decision-making from enduring personality, clinical illness, and social judgments about cannabis users.

The oral doses were placebo, 7.5 mg THC, and 15 mg THC. Forty participants completed all three sessions; the paper reports another 18 with the abbreviated placebo/high-dose schedule. The dose-specific comparisons are more informative than a broad assertion that any cannabis exposure necessarily eliminates motivation.

Related reading: task-specific cognitive findings after cannabis.

Primary research

Margaret C. Wardle; Elisa Pabon; Heather E. Webber; Harriet de Wit. Delta-9-tetrahydrocannabinol reduces willingness to exert effort in women. Psychopharmacology (2022). DOI: 10.1007/s00213-021-06032-1.

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

Plant Raman Testing for THC and CBD: Why Sampling the Right Tissue Matters

Where a Raman instrument samples a cannabis plant can determine whether it obtains useful cannabinoid information. A 42-plant study found informative THC- and CBD-related signals in glandular-trichome-rich regions, while other leaf and stem regions did not provide the same information. Why the wavelength and tissue mattered Porcu and colleagues investigated…

Spread the love

Read Article: Plant Raman Testing for THC and CBD: Why Sampling the Right Tissue Matters

Nabiximols and Urine Screening: A Dose Correlation Is Not an Impairment Measurement

A urine cannabinoid screen can correlate with a prescribed nabiximols dose without measuring impairment. In a small multiple-sclerosis study, the relationship concerned ongoing treatment exposure and laboratory response. It did not establish an acute driving-risk threshold or a way to calculate an individual’s exact dose from one specimen. Who was…

Spread the love

Read Article: Nabiximols and Urine Screening: A Dose Correlation Is Not an Impairment Measurement

Why 98.7% Fingerprint THC Agreement Needs Its Underlying Counts

A fingerprint THC screen achieved 98.7% agreement with laboratory fingerprint testing in 75 postmortem cases. The underlying counts were 73 true negatives, one true positive and one false positive. Those numbers convey much more about the evidence than the headline percentage alone. What “accuracy” referred to Hudson and colleagues evaluated…

Spread the love

Read Article: Why 98.7% Fingerprint THC Agreement Needs Its Underlying Counts

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us